1 Cite Share Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer. Wei P, Jordan KR, Buhrman JD, Lei J, Deng H, Marrack P, Dai S, Kappler JW, Slansky JE, Yin L. Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):e2100588118. doi: 10.1073/pnas.2100588118. PMID: 34074778 Free PMC article. 2 Cite Share 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro. Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G. MAbs. 2021 Jan-Dec;13(1):1919285. doi: 10.1080/19420862.2021.1919285. PMID: 34074219 Free PMC article. 3 Cite Share The basis of a more contagious 501Y.V1 variant of SARS-CoV-2. Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, Downing W, Jiang C, Liang B, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G. Cell Res. 2021 Jun;31(6):720-722. doi: 10.1038/s41422-021-00496-8. Epub 2021 Apr 23. PMID: 33893398 Free PMC article. No abstract available.